Log in to save to my catalogue

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Diseas...

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Diseas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ca8d9c8c1ddc49cda262f32703207fe1

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease

About this item

Full title

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease

Publisher

United States: John Wiley & Sons, Inc

Journal title

Hepatology Communications, 2022-05, Vol.6 (5), p.1032-1044

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Nonalcoholic fatty liver disease (NAFLD) is an emerging cause of liver‐related events (LREs). Here, we have assessed the ability of a composite score based on clinical features, metabolic comorbidities, and genetic variants to predict LREs. A total of 546 consecutive patients with NAFLD were recruited and stratified according to the fibrosis‐4 (FIB...

Alternative Titles

Full title

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ca8d9c8c1ddc49cda262f32703207fe1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ca8d9c8c1ddc49cda262f32703207fe1

Other Identifiers

ISSN

2471-254X

E-ISSN

2471-254X

DOI

10.1002/hep4.1877

How to access this item